MAIA Biotechnology announced positive interim survival data for its lead candidate, THIO, in a Phase II trial for advanced ...

The Austrian Academy of Sciences (OeAW) is further expanding its focus on life sciences by opening an institute for biomedical artificial intelligence (AI) based on a 150 million euros ($166.8 million ...

The US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) ...

Novo Nordisk is under pressure over US drug prices as CEO Lars Fruergaard Jørgensen prepares to testify before the Senate ...

Athira Pharma is refocusing efforts on ATH-1105 after its Alzheimer’s drug, fosgonimeton, failed to meet endpoints in the ...

Coherus Biosciences has seen a 24% drop in share price due to supply chain issues affecting Udenyca (pegfilgrastim-cbqv), a ...

In a lawsuit filed in federal court in Missouri, USA, Health insurer Cigna (NYSE: CI) and its pharmacy benefit manager (PBM) ...

Los Angeles-based City of Hope has received a $150 million donation from investor Emmet Stephenson and his daughter, Tessa, ...

Gene therapy research in Japan has gained significant momentum due to the SAKIGAKE designation system and government-led ...

Yesterday, the US Food and Drug Administration (FDA) issued a draft guidance, “Integrating Randomized Controlled Trials for ...

Structure Therapeutics has announced leadership changes to enhance its clinical development operations. Blai Coll has been ...

The HERTHENA-Lung02 Phase III trial of patritumab deruxtecan in advanced EGFR-mutated NSCLC patients who received prior EGFR ...